|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
Monsanto (by Bayer AG, 2018)
Schering AG (2006)
|
|
gptkbp:CEO
|
Bill Anderson (Bayer AG, 2023)
|
|
gptkbp:country
|
gptkb:Germany
|
|
gptkbp:focusArea
|
gptkb:Women's_Health
Cardiology
Oncology
Ophthalmology
Hematology
|
|
gptkbp:foundedYear
|
1863
|
|
gptkbp:founder
|
gptkb:Friedrich_Bayer
|
|
gptkbp:hasResearchCenter
|
gptkb:Berlin,_Germany
gptkb:Wuppertal,_Germany
|
|
gptkbp:headquartersLocation
|
gptkb:Leverkusen,_Germany
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bayer Pharmaceuticals
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:notableProduct
|
gptkb:Yaz
gptkb:Aspirin
gptkb:Eylea
gptkb:Kogenate
gptkb:Mirena
gptkb:Xarelto
|
|
gptkbp:numberOfEmployees
|
~100,000 (Bayer AG, 2023)
|
|
gptkbp:parentCompany
|
gptkb:Bayer_AG
|
|
gptkbp:revenue
|
€50.7 billion (Bayer AG, 2022)
|
|
gptkbp:slogan
|
gptkb:Science_For_A_Better_Life
|
|
gptkbp:stockExchange
|
FWB (Frankfurt Stock Exchange) (as Bayer AG)
|
|
gptkbp:stockSymbol
|
BAYN (as Bayer AG)
|
|
gptkbp:subsidiary
|
gptkb:Bayer_AG
|
|
gptkbp:website
|
https://pharma.bayer.com/
|
|
gptkbp:bfsParent
|
gptkb:vardenafil
|
|
gptkbp:bfsLayer
|
6
|